1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Aucta Pharmaceuticals, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects Entecavir - HBV | Phase 1 | Completed | Aucta Pharmaceuticals, Inc | 40 | 2017-10-20 | 2018-06-27 |
| Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment - Angiofibroma of Face, Tuberous Sclerosis | Phase 2 | Terminated | Aucta Pharmaceuticals, Inc | 24 | 2017-04-12 | 2025-12-01 |
Erythema (1) · Exanthema (1) · Facies (1) · Fibroma (1) · Tuberous Sclerosis (1)
Australia (1) · China (1) · United States (1)